ARTICLES BY THIS AUTHOR
- 11/4/2013
Intuniv XR: first alpha agonist approved for ADHD
Shire Canada is introducing Intuniv XR (guanfacine 1 mg, 2 mg, 3mg, and 4 mg extended-release tablets), the first selective alpha2A-adrenergic receptor agonist to be approved for the treatment of attention deficit hyperactivity disorder (ADHD) in Canada. - 11/4/2013
Nurses’ union cites poor conditions
- 11/4/2013
New option for pancreatic cancer
- 11/4/2013
Rockin’ around the Thanks-hallow-mas tree
For a stress-free holiday season, this combo-pack of festivity might be just what the doctor ordered - 11/4/2013
It is an honour to care for you
The faint blue lines on my patient’s forearm started a conversation that has given me strength and hope - 11/4/2013
Seven tips for a successful grassroots recruitment campaign
Emphasize your strengths and tap into local doctors as a resource to direct your efforts - 11/4/2013
WMA to reinstate suspended president
Indian doctor now cleared of graft charges will be president of World Medical Association